期刊文献+

帕金森病患者血清中铜、铁、锰、锌和维生素E、维生素B12的测定 被引量:6

Study on the Relationship between Serum Cu、Fe、Mn、Zn、Vitamin E、Vitamin B12 Level and Parkinson's Disease
原文传递
导出
摘要 目的探讨帕金森病患者血清中铜、铁、锰、锌和维生素E、维生素B12与帕金森病的关系。方法采用1∶1配对的病例对照研究方法,收集最近4年内新发帕金森病病例40例和年龄(±3岁)、性别、职业、文化程度匹配的对照者40例,采用经石墨炉原子吸收法测定帕金森病患者和对照组血清中微量元素锰含量;帕金森病患者和对照组血清中微量元素铜、铁、锌的含量则用电感耦合等离子体发射光谱ICP直接测定法,用高效液相色谱来测定帕金森病患者和对照组血清中维生素E、维生素B12的含量,并进行配对t检验分析。结果帕金森病患者血清中锰、铁含量高于对照组(P<0.05),而两组间铜、锌、维生素E、维生素B12含量则无明显差异(P>0.05)。结论血清微量元素锰、铁可能是帕金森病发病的重要影响因素之一。 Objective To study the relationship between serum Cu.Fe.Mn.Zn.Vitamin E.Vitamin B12 level and Parkinson's disease(PD). Methods We enrolled 40 cases of PD patients in last 4 years and 40 cases of age-, sex-, and race-, frequency-matched controls in a case control study. Serum concentration of Mn was measured with graphite atomic absorption, Cu. Fe. Zn with Inductively Coupled Plasma Mass Spectrometry (ICP), and the Vitamin E.Vitamin B12 level with High-performance liquid chromatography(HPLC). Results Concentration of Fe.Mn were significantly higher in PD patients than that in the controls(P〈0. 05), while the Cu.Zn.Vitamin E. Vitamin B12 concentration in PD patients was not significantly different from that in the controls(P〉0. 05). Conclusions The pathogenesis and development of PD might be related to some trace met- als especially Fe and Mn.
出处 《卒中与神经疾病》 2012年第4期219-221,共3页 Stroke and Nervous Diseases
基金 湖北医药学院附属襄阳医院与武汉大学公共卫生学院及日本Fukushima医科大学合作项目 由日本政府资助
关键词 帕金森病 微量元素 维生素 Parkinson's disease (PD) Trace metal Vitamin
  • 相关文献

参考文献2

二级参考文献14

  • 1[1]Gelman BB. Iron in CNS disease. J Neuropath Experiment Neurol, 1995, 54:477~486.
  • 2[2]He Y, Lee T, Leong SK,et al. Time course and localization of transferrin receptor expression in the substantia nigra of 6-hydoxydopmine induced Parkinsonian rats. Neuroscience,1999, 91:579~585.
  • 3[3]Fillebeen C, Mitchell V, Dexter D. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Brain Res mol, 1999, 72:183~194.
  • 4[4]Patel BN, Dunn RJ, David S. Alternative RNA splicing generates a glyco- sylphosphatidylinositol-abchored form of ceruloplasmin in mammalian brain. J Biol Chem, 2000, 275:4305~4310.
  • 5[5]Boll MC, Sotelo J, Otero E,et al. Reduced ferroxidase activity in the cerebrospinal fluid from patients with parkinson's disease. Neurosci lett, 1999, 253:155~158.
  • 6[6]Torsdottir G, Kistinsson J, Sveinbjornsdottir S. Copper,ceruloplasmin,superoxide dismutase and iron parameters in parkinson's disease. Pharmacol Toxicol, 1999, 85:239~243.
  • 7[7]Zhong MQ, Ya K. Rethinking the role of ceruloplasmin in brain iron metabolism. Brain Res Reviews, 2001, 35:287~294.
  • 8[8]Van Eden ME, Aust SD. Intact human ceruloplasmin is repuired for the incorporation of iron into human ferritin. Arch Biochem Biophys, 2000, 381:119~126.
  • 9[9]Rouault TA. Iron on the brain. Nature Genetics, 2001, 28:299~300.
  • 10Zatta P, Lucchini R, van Rensburg SJ, et al. The role of metals in neurodegenerative processes: aluminum, manganese,and zinc[J]. Brain Res Bull, 2003,62:15-28.

共引文献18

同被引文献106

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部